학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 27건 | 목록
1~20
Academic Journal
Raicevic Toungouz G; Cancer Center, Sciensano (SC), Brussels, Belgium. Electronic address: Gordana.RaicevicToungouz@sciensano.be.; Alessandrello R; Innovation Unit, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain.; Giacomini P; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOSD Medicina di Precisione in Senologia, Rome, Italy; Alleanza Contro Il Cancro (ACC), Rome, Italy.; Kamal M; Department of Drug Development & Innovation, Institut Curie (IC), Paris, France; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, France.; Gausachs M; Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Mazzarella L; Alleanza Contro Il Cancro (ACC), Rome, Italy; Department of Experimental Oncology, European Institute of Oncology (IEO)-IRCCS, Milan, Italy.; Sujobert P; Laboratory of Haematology, Hospices Civils de Lyon (HCL), Hôpital Lyon Sud, Lyon, France.; Frigè G; Alleanza Contro Il Cancro (ACC), Rome, Italy; Department of Experimental Oncology, European Institute of Oncology (IEO)-IRCCS, Milan, Italy.; Alay A; Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Planchon JM; Department of Genetics, Institut Curie (IC), Paris, France.; Blau O; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin (HC), Berlin, Germany.; Mias Carballal MR; Innovation Unit, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain.; Antoine-Poirel H; Cancer Center, Sciensano (SC), Brussels, Belgium.; Nadal E; Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin (HC), Berlin, Germany.; Hebrant A; Cancer Center, Sciensano (SC), Brussels, Belgium.; Servant N; Bioinformatics Core Facility, INSERM U1331, Mines Paris Tech, Institut Curie (IC), Paris, France.; D'Haene N; Medical Oncology Department, Institut Jules Bordet (IJB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.; Aftimos P; Medical Oncology Department, Institut Jules Bordet (IJB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.; Silkenstedt E; Department of Medicine III, University Hospital Groβhadern, Ludwig Maximilians University (LMU), Munich, Germany.; Michalík A; De Clercq & Partners (DCP), Sint-Martens-Latem, Belgium.; Dupain C; Department of Drug Development & Innovation, Institut Curie (IC), Paris, France.; Delcourt T; Cancer Center, Sciensano (SC), Brussels, Belgium.; Huet S; Laboratory of Haematology, Hospices Civils de Lyon (HCL), Hôpital Lyon Sud, Lyon, France.; Van Campenhout C; Medical Oncology Department, Institut Jules Bordet (IJB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.; Cordero D; Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Castellano Garcia JM; Innovation Unit, Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain.; Codony C; Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Krol A; Institut National du Cancer (INCa), Boulogne-Billancourt, France.; Gonzalo J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Van Damme N; Belgian Cancer Registry (BCR), Brussels, Belgium.; Delnord M; Cancer Center, Sciensano (SC), Brussels, Belgium.; Carbone R; Alleanza Contro Il Cancro (ACC), Rome, Italy; Department of Experimental Oncology, European Institute of Oncology (IEO)-IRCCS, Milan, Italy.; Trapani V; Alleanza Contro Il Cancro (ACC), Rome, Italy; Saint Camillus International University of Health and Medical Sciences, Rome, Italy.; Van Garsse S; EQUATOR, Antwerp, Belgium.; Van Den Bulcke M; Cancer Center, Sciensano (SC), Brussels, Belgium.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Christen, F; Hoyer, K; Yoshida, K; Hou, H-A; Waldhueter, N; Heuser, M; Hills, RK; Chan, W; Hablesreiter, R; Blau, O; Ochi, Y; Klement, P; Chou, W-C; Blau, I-W; Tang, J-L; Zemojtel, T; Shiraishi, Y; Shiozawa, Y; Thol, F; Ganser, A; Löwenberg, B; Linch, DC; Bullinger, L; Valk, PJM; Tien, H-F; Gale, RE; Ogawa, S; Damm, F
Blood. 133:1140-1151
Academic Journal
Hoyer K; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Hablesreiter R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Inoue Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Yoshida K; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Briest F; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Christen F; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Kakiuchi N; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Yoshizato T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Shiozawa Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Shiraishi Y; Laboratory of DNA information Analysis, Human Genome Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Striefler JK; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Bischoff S; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Lohneis P; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany; Institute of Pathology, University of Cologne, Cologne, Germany.; Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Blau O; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Bullinger L; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Pelzer U; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Hummel M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.; Riess H; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany.; Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan; Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.; Sinn M; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Damm F; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin 13353, Germany; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: frederik.damm@charite.de.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Academic Journal
Blau IW; Medizinische Klinik III (Hämatologie, Onkologie und Transfusionsmedizin), Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany.; Schmidt-Hieber M; Leschinger N; Göldner H; Knauf W; Hopfenmüller W; Thiel E; Blau O
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0939-5555 (Print) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Academic Journal
Academic Journal
Avigad S; Cancer Molecular Genetics, Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tiqva.; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium: Print ISSN: 0950-9232 (Print) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Academic Journal
Academic Journal
Academic Journal
Blau O; Cancer Molecular Genetics, Felsenstein Medical Research Centre, Schneider Children's Medical Center of Israel, Petah Tiqva.; Avigad S; Frisch A; Kilim Y; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print Cited Medium: Print ISSN: 0145-2126 (Print) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Academic Journal
Blau O; Felsenstein Medical Research Center, Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Israel.; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print Cited Medium: Print ISSN: 0145-2126 (Print) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Academic Journal
Tamary H; Pediatric Hematology Oncology Center, Schneider Children's Medical Center of Israel.; Fromovich Y; Shalmon L; Reich Z; Dym O; Lanir N; Brenner B; Paz M; Luder AS; Blau O; Korostishevsky M; Zaizov R; Seligsohn U
Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print Cited Medium: Print ISSN: 0340-6245 (Print) Linking ISSN: 03406245 NLM ISO Abbreviation: Thromb Haemost Subsets: MEDLINE
Academic Journal
Stark B; Department of Pediatric Oncology/Hematology, Children's Medical Center of Israel, Petah Tiqva.; Resnitzky P; Jeison M; Luria D; Blau O; Avigad S; Shaft D; Kodman Y; Gobuzov R; Ash S; et. al.
Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print Cited Medium: Print ISSN: 0145-2126 (Print) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Academic Journal
WASSERMAN, L; AVIRAM, R; LEVAVI, H; OVADIA, J; SHNEYUOR, Y; FRISCH, A; BLAU, O; BEERY, E; NOVOGRODSKY, A; NORDENBERG, J
Academic Journal
Academic Journal
Academic Journal
검색 결과 제한하기
제한된 항목
[AR] Blau, O
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어